Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
AstraZeneca
Johnson and Johnson
Medtronic
Colorcon

Last Updated: October 17, 2019

DrugPatentWatch Database Preview

Somatropin recombinant - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for somatropin recombinant and what is the scope of patent protection?

Somatropin recombinant is the generic ingredient in six branded drugs marketed by Emergent, Lilly, Novo Nordisk Inc, Genentech, Lg Chem Ltd, and Emd Serono, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for somatropin recombinant. Two suppliers are listed for this compound.

Recent Clinical Trials for somatropin recombinant

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Parc de Salut MarPhase 1
Ache Laboratorios Farmaceuticos S.A.Phase 4
The University of Texas Medical Branch, GalvestonPhase 3

See all somatropin recombinant clinical trials

Recent Litigation for somatropin recombinant

Identify potential future generic entrants

District Court Litigation
Case NameDate
Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc.2017-03-03
SMITH v. NOVO NORDISK INC.2016-08-08
Kyphon, Inc. v. Phan2007-08-21

See all somatropin recombinant litigation

US Patents and Regulatory Information for somatropin recombinant

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Emd Serono ZORBTIVE somatropin recombinant INJECTABLE;INJECTION 021597-001 Dec 1, 2003 DISCN No No   Start Trial   Start Trial   Start Trial
Lilly HUMATROPE somatropin recombinant INJECTABLE;INJECTION 019640-004 Mar 8, 1987 BX RX Yes Yes   Start Trial   Start Trial   Start Trial
Lilly HUMATROPE somatropin recombinant INJECTABLE;INJECTION 019640-001 Jun 23, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for somatropin recombinant

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novo Nordisk Inc NORDITROPIN somatropin recombinant INJECTABLE;INJECTION 019721-001 May 8, 1995   Start Trial   Start Trial
Genentech NUTROPIN DEPOT somatropin recombinant INJECTABLE;INJECTION 021075-003 Dec 22, 1999   Start Trial   Start Trial
Genentech NUTROPIN DEPOT somatropin recombinant INJECTABLE;INJECTION 021075-003 Dec 22, 1999   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Medtronic
Mallinckrodt
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.